ASSURE study of experimental agent to raise HDL yields 'disappointing and surprising' results The search continues for an agent that increases high-density lipoprotein and reduces arterial plaque, after the experimental apolipoprotein A1 (apoA1) inducer, RVX-208 failed to do so in the ApoA1 Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation study.
Sept. 2, 2013 - Science Daily